ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 842

Partial and Complete Recovery From Proteinuria in Lupus Nephritis Patients Receiving Standard of Care Treatment

Zahi Touma1, D. D. Gladman2, Dominique Ibanez3 and Murray B. Urowitz3, 1Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 2Division of Rheumatology, Toronto Western Hospital and University of Toronto, Toronto, ON, Canada, 3Division of Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: lupus nephritis and proteinuria

  • Tweet
  • Email
  • Print
Session Information

Title: Systemic Lupus Erythematosus - Clinical Aspects and Treatment I: Renal

Session Type: Abstract Submissions (ACR)

Background/Purpose:

In the majority of trials on lupus, partial proteinuria recovery (PPR) (≥ 50% decrease in the proteinuria level) is a component of the composite outcome of partial renal remission.

To determine the percentage of patients who achieve complete proteinuria recovery (CPR), PPR and CPR and/or PPR in lupus nephritis (LN) patients receiving standard treatment at 6 months, 1 year and 2 years. The am of this study was to determine if the initial level of proteinuria predicts recovery from proteinuria.

 

Methods:

We studied all active LN patients registered at the Lupus Clinic (1970-2011).  Proteinuria was defined as >0.5g/24 hours based on a 24 hour urine collection. Patients with proteinuria and at least one of the urinary sediments (hematuria, pyuria or casts) present at the entry of the study and persistent on 2 consecutive visits were enrolled. Patients were grouped into: group 1 as 0.5-0.9g/day, group 2 as 1-2g/day and group 3 as ≥2g/day.

 

CPR was defined as proteinuria <0.5g/24 hours based on SLEDAI-2K. PPR was a decrease of ≥ 50% in the level of proteinuria from baseline as defined by by SLEDAI-50 responder index (SLEDAI-50-RI).

 

We determined the percentage of PPR, CPR and PPR and/or CPR achieved: 1) on 1 visit at 6 months, 1 year and 2 years 2) persistent on 2 consecutive visits at 6 months, 1 year and 2 years. The percentage of patients who recovered from proteinuria was evaluated based on initial proteinuria levels with the Kaplan-Meier estimator.

 

Results:

217 patients (81.8% female) were identified. The age and duration of lupus at the start of the study was 34.2 ± 12.4 and 5.7 ± 6.3 years.

PPR was achieved by 27% of patients at 6 months, 48.3% at 1 year and 69.4% at 2 years. PPR and/ or CPR was achieved by 31.8% of patients at 6 months, 57.6% at 1 year and 79.3% at 2 years. CPR was achieved by 8.8% of patients at 6 months, 35.2% at 1 year and 60.2% at 2 years (table 1). The percentage of PPR, CPR and PPR and/or CPR decreased when proteinuria recovery was required on 2 consecutive visits (Table 1) (Figure 1).

 

Based on the level of proteinuria, in group 1, 2 and 3 more patients achieved at least PPR compared to CPR at 6 months (p=0.81), 1 and 2 years (p<0.05).

 

Conclusion:

The identification of partial proteinuria recovery allowed the detection of additional patients who improved their proteinuria on standard of care treatment. 58% of patients achieved at least partial while only 35% achieved CPR at year 1. PPR can serve as an important primary endpoint in research studies and trials.

Table 1. Percentage of PPR, CPR, and PPR or CPR using 1 visit or 2 visits what does this mean 

Definitions

Percent of patients who have proteinuria recovery

@ 6 months

@ 1 year

@ 2 years

1 visit

2 visits

1 visit

2 visits

1 visit

2 visits

Partial recovery

27%

21%

48.3%

35.8%

69.4%

50.9%

Complete recovery

8.8%

6.9%

35.2%

24.8%

60.2%

45.7%

Partial or complete recovery

31.8%

25.5%

57.6%

46.4%

79.3%

65.9%

 

Figure 1. Comparing Complete, Partial, Partial and/or Complete – All Patients – 1 Visit Definition

 


Disclosure:

Z. Touma,
None;

D. D. Gladman,
None;

D. Ibanez,
None;

M. B. Urowitz,
None.

  • Tweet
  • Email
  • Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/partial-and-complete-recovery-from-proteinuria-in-lupus-nephritis-patients-receiving-standard-of-care-treatment/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology